JPRN-UMIN000012015招募中未知
Development of TDM-guided treatment with daptomycin based on PK/PD theory by measurement of plasma concentration of daptomycin. - PK/PD of Daptomycin
Infection control team of Osaka Medical College Hospital0 个研究点目标入组 30 人开始时间: 2013年10月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
Unknown
不适用
The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.AntibioticNCT04546815Jiangsu Hengrui Pharmaceutical Co., Ltd.2,000
进行中（未招募）
不适用
Treatment of MDS patients with single agent temsirolimus – a pilot studyMyelodysplastic Syndromes (MDS)(20 IPSS LOW+INT-1 and 20 IPSS INT-2+HIGH or proliferating CMML)MedDRA version: 14.1Level: PTClassification code 10028533Term: Myelodysplastic syndromeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-014768-21-DEDresden Technical University
已完成
不适用
Evaluation of TDCS for augmentation treatment of major depressive disorder with poor treatment responseMajor depressive disorder.Mild depressive episodeIRCT2016012526189N1dr. Masud yunesian.manager of research affairs of Tehran University of Medical Sciencses30
进行中（未招募）
1 期
Adjunction of daptomycin for the treatment of pneumococcal meningitis AddaMAP studyMedDRA version: 20.0 Level: PT Classification code 10027253 Term: Meningitis pneumococcal System Organ Class: 10021881 - Infections and infestationsEUCTR2017-002888-18-FRCHU Dijon Bourgogne128
已完成
3 期
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)Acute Hematogenous OsteomyelitisNCT01922011Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)149